The anxiolytic effect of a promising quinoline containing selenium with the contribution of the serotonergic and GABAergic pathways: Modulation of parameters associated with anxiety in mice

Nuss, 2015, Anxiety disorders and GABA neurotransmission: a disturbance of modulation, Neuropsychiatr. Dis. Treat., 11, 165 Belzung, 2001, Measuring normal and pathological anxiety-like behaviour in mice: a review, Behav. Brain Res., 125, 141, 10.1016/S0166-4328(01)00291-1 World Health Organization, 2017 Mariotti, 2015, The effects of chronic stress on health: new insights into the molecular mechanisms of brain-body communication, Futur. Sci. OA., 1, 10.4155/fso.15.21 Elnazer, 2014, Investigation of cortisol levels in patients with anxiety disorders: a structured review, Curr. Top. Behav. Neurosci., 18, 191, 10.1007/7854_2014_299 Duman, 2006, A neurotrophic model for stress-related mood disorders, Biol. Psychiatry, 59, 1116, 10.1016/j.biopsych.2006.02.013 Reichardt, 2006, Neurotrophin-regulated signalling pathways, Philos. Trans. R. Soc. B Biol. Sci., 361, 1545, 10.1098/rstb.2006.1894 Wand, 2005, The anxious amygdala: CREB signaling and predisposition to anxiety and alcoholism, J. Clin. Invest., 115, 2697, 10.1172/JCI26436 Wallace, 2009, CREB regulation of nucleus accumbens excitability mediates social isolation-induced behavioral deficits, Nat. Neurosci., 12, 200, 10.1038/nn.2257 Oeckinghaus, 2009, The NF-kappaB family of transcription factors and its regulation, Cold Spring Harb. Perspect. Biol., 1, 10.1101/cshperspect.a000034 Möhler, 2005, Pathophysiology and pharmacology of GABA(A) receptors, Handb. Exp. Pharmacol., 225, 10.1007/3-540-28082-0_9 Lanzenberger, 2007, Reduced serotonin-1A receptor binding in social anxiety disorder, Biol. Psychiatry, 61, 1081, 10.1016/j.biopsych.2006.05.022 Pinz, 2016, 4-Phenylselenyl-7-chloroquinoline, a new quinoline derivative containing selenium, has potential antinociceptive and anti-inflammatory actions, Eur. J. Pharmacol., 780, 122, 10.1016/j.ejphar.2016.03.039 Silva, 2017, Further analysis of acute antinociceptive and anti-inflammatory actions of 4-phenylselenyl-7-chloroquinoline in mice, Fundam. Clin. Pharmacol., 31, 513, 10.1111/fcp.12295 Reis, 2017, 4-phenylselenyl-7-chloroquinoline, a novel multitarget compound with anxiolytic activity: contribution of the glutamatergic system, J. Psychiatr. Res., 84, 191, 10.1016/j.jpsychires.2016.10.007 Vogt, 2018, Organoselenium group is critical for antioxidant activity of 7-chloro-4-phenylselenyl-quinoline, Chem. Biol. Interact., 282, 7, 10.1016/j.cbi.2018.01.003 Voss, 2018, Therapeutic and technological potential of 7-chloro-4-phenylselanyl quinoline for the treatment of atopic dermatitis-like skin lesions in mice, Mater. Sci. Eng. C Mater. Biol. Appl., 84, 90, 10.1016/j.msec.2017.11.026 Pinz, 2018, Current advances of pharmacological properties of 7-chloro-4-(phenylselanyl) quinoline: prevention of cognitive deficit and anxiety in Alzheimer’s disease model, Biomed. Pharmacother., 105, 1006, 10.1016/j.biopha.2018.06.049 Barth, 2019, 7-chloro-4-(Phenylselanyl) quinoline with memory enhancer action in aging rats: modulation of neuroplasticity, acetylcholinesterase activity, and cholesterol levels, Mol. Neurobiol., 56, 6398, 10.1007/s12035-019-1530-5 Duarte, 2017, A simple method for the synthesis of 4-arylselanyl-7-chloroquinolines used as in vitro acetylcholinesterase inhibitors and in vivo memory improvement, Tetrahedron Lett., 58, 3319, 10.1016/j.tetlet.2017.07.039 Walsh, 1976, The open-field test: a critical review, Psychol. Bull., 83, 482, 10.1037/0033-2909.83.3.482 McIlwain, 2001, The use of behavioral test batteries: effects of training history, Physiol. Behav., 73, 705, 10.1016/S0031-9384(01)00528-5 Pellow, 1985, Validation of open : closed arm entries in an elevated plus-maze as a measure of anxiety in the rat, J. Neurosci. Methods, 14, 149, 10.1016/0165-0270(85)90031-7 Jesse, 2009, Further analysis of the antinociceptive action caused by p-methoxyl-diphenyl diselenide in mice, Pharmacol. Biochem. Behav., 91, 573, 10.1016/j.pbb.2008.09.012 Jung, 2002, The discriminative stimulus effects of pentylenetetrazol as a model of anxiety: recent developments, Neurosci. Biobehav. Rev., 26, 429, 10.1016/S0149-7634(02)00010-6 Rostampour, 2016, Anxiolytic-like effect of hydroalcoholic extract of ripe pistachio hulls in adult female Wistar rats and its possible mechanisms, Res. Pharm. Sci., 11, 454, 10.4103/1735-5362.194870 Fiske, 1925, The colorimetric determination of phosphorus, J. Biol. Chem., 375, 10.1016/S0021-9258(18)84756-1 Loetchutinat, 2005, Spectrofluorometric determination of intracellular levels of reactive oxygen species in drug-sensitive and drug-resistant cancer cells using the 2′,7′-dichlorofluorescein diacetate assay, Radiat. Phys. Chem., 72, 323, 10.1016/j.radphyschem.2004.06.011 Bradford, 1976, A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding, Anal. Biochem., 72, 248, 10.1016/0003-2697(76)90527-3 Zenker, 1958, The estimation of small amounts of corticosterone in rat plasma, J. Biol. Chem., 231, 695, 10.1016/S0021-9258(18)70434-1 Livak, 2001, Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method, Methods., 25, 402, 10.1006/meth.2001.1262 Żmudzka, 2018, Serotonin receptors in depression and anxiety: insights from animal studies, Life Sci., 210, 106, 10.1016/j.lfs.2018.08.050 Bandelow, 2017, Treatment of anxiety disorders, Dialogues Clin. Neurosci., 19, 93, 10.31887/DCNS.2017.19.2/bbandelow Akimova, 2009, The serotonin-1A receptor in anxiety disorders, Biol. Psychiatry, 66, 627, 10.1016/j.biopsych.2009.03.012 Koen, 2011, Pharmacotherapy of anxiety disorders: a critical review, Dialogues Clin. Neurosci., 13, 423, 10.31887/DCNS.2011.13.4/nkoen Jiang, 2011, Pharmacology of 5-HT2 modulation of amygdala & hypothalamus in anxiety disorders, Anxiety Disord. Res., 39 Quesseveur, 2012, 5-HT2 ligands in the treatment of anxiety and depression, Expert Opin. Investig. Drugs, 21, 1701, 10.1517/13543784.2012.719872 Nemeroff, 2003, The role of GABA in the pathophysiology and treatment of anxiety disorders, Psychopharmacol. Bull., 37, 133 Möhler, 2002, Pathophysiological aspects of diversity in neuronal inhibition: a new benzodiazepine pharmacology, Dialogues Clin. Neurosci., 4, 261, 10.31887/DCNS.2002.4.3/hmoehler Sharma, 2017, Methanol extract of artocarpus heterophyllus attenuates pentylenetetrazole induced anxiety like behaviours in mice, J. Med. Plants Stud., 5, 181 Cloos, 2009, Current use of benzodiazepines in anxiety disorders, Curr. Opin. Psychiatry, 22, 90, 10.1097/YCO.0b013e32831a473d Uzun, 2010, Side effects of treatment with benzodiazepines, Psychiatr. Danub., 22, 90 Anisman, 2005, Stress, depression, and anhedonia: caveats concerning animal models, Neurosci. Biobehav. Rev., 29, 525, 10.1016/j.neubiorev.2005.03.007 Jacobson, 2014, Hypothalamic-pituitary-adrenocortical axis: neuropsychiatric aspects, Compr. Physiol., 4, 715, 10.1002/cphy.c130036 Escobar, 2002, Neuroanatomía del estrés Artículo de revisión, Rev. Mex. Neuroc., 3, 273 Lowy, 1984, Glucocorticoid resistance in depression: the dexamethasone suppression test and lymphocyte sensitivity to dexamethasone, Am. J. Psychiatry, 141, 1365, 10.1176/ajp.141.11.1365 Bartanusz, 2004, Local γ-aminobutyric acid and glutamate circuit control of hypophyseotrophic corticotropin-releasing factor neuron activity in the paraventricular nucleus of the hypothalamus, Eur. J. Neurosci., 19, 777, 10.1111/j.1460-9568.2004.03167.x de Baumont, 2019, Anxiety disorders in childhood are associated with youth IL-6 levels: a mediation study including metabolic stress and childhood traumatic events, J. Psychiatr. Res., 115, 43, 10.1016/j.jpsychires.2019.05.011 Halliwell, 2006, Oxidative stress and neurodegeneration: where are we now?, J. Neurochem., 97, 1634, 10.1111/j.1471-4159.2006.03907.x Bouayed, 2009, Oxidative stress and anxiety relationship and cellular pathways, Oxid. Med. Cell. Longev., 2, 63, 10.4161/oxim.2.2.7944 Berry, 2008, Deletion of the lifespan determinant p66(Shc) improves performance in a spatial memory task, decreases levels of oxidative stress markers in the hippocampus and increases levels of the neurotrophin BDNF in adult mice, Exp. Gerontol., 43, 200, 10.1016/j.exger.2007.10.016 Kumar, 2014, Buspirone along with melatonin attenuates oxidative damage and anxiety-like behavior in a mouse model of immobilization stress, Chin. J. Nat. Med., 12, 582 Skou, 1992, The Na,K-ATPase, J. Bioenerg. Biomembr., 24, 249, 10.1007/BF00768846 Crema, 2010, Na+, K+ ATPase activity is reduced in amygdala of rats with chronic stress-induced anxiety-like behavior, Neurochem. Res., 35, 1787, 10.1007/s11064-010-0245-9 Morel, 1998, Effects of 4-hydroxynonenal, a lipid peroxidation product, on dopamine transport and Na+/K+ ATPase in rat striatal synaptosomes, Neurochem. Int., 33, 531, 10.1016/S0197-0186(98)00062-X Carlezon, 2005, The many faces of CREB, Trends Neurosci., 28, 436, 10.1016/j.tins.2005.06.005 Pandey, 2005, Deficits in amygdaloid cAMP-responsive element-binding protein signaling play a role in genetic predisposition to anxiety and alcoholism, J. Clin. Invest., 115, 2762, 10.1172/JCI24381 Yoshii, 2010, Postsynaptic BDNF-TrkB signaling in synapse maturation, plasticity, and disease, Dev. Neurobiol., 70, 304, 10.1002/dneu.20765 Smith, 1995, Stress and glucocorticoids affect the expression of brain-derived neurotrophic factor and neurotrophin-3 mRNAs in the hippocampus, J. Neurosci., 15, 1768, 10.1523/JNEUROSCI.15-03-01768.1995 Gourley, 2009, A history of corticosterone exposure regulates fear extinction and cortical NR2B, GluR2/3, and BDNF, Neuropsychopharmacology, 34, 707, 10.1038/npp.2008.123 Suri, 2013, Glucocorticoid regulation of brain-derived neurotrophic factor: relevance to hippocampal structural and functional plasticity, Neuroscience, 239, 196, 10.1016/j.neuroscience.2012.08.065 Siomek, 2012, NF-κB signaling pathway and free radical impact, Acta Biochim. Pol., 59, 323, 10.18388/abp.2012_2116 Gargouri, 2018, Inflammatory and oxidative mechanisms potentiate bifenthrin-induced neurological alterations and anxiety-like behavior in adult rats, Toxicol. Lett., 294, 73, 10.1016/j.toxlet.2018.05.020 Lingappan, 2018, NF-κB in oxidative stress, Curr. Opin. Toxicol., 7, 81, 10.1016/j.cotox.2017.11.002 Li, 2017, Ulinastatin downregulates TLR4 and NF-kB expression and protects mouse brains against ischemia/reperfusion injury, Neurol. Res., 39, 367, 10.1080/01616412.2017.1286541 Fukuchi, 2017, Visualizing changes in brain-derived neurotrophic factor (BDNF) expression using bioluminescence imaging in living mice, Sci. Rep., 7, 4949, 10.1038/s41598-017-05297-x Shankar, 2005, The role of CREB as a proto-oncogene in hematopoiesis and in acute myeloid leukemia, Cancer Cell, 7, 351, 10.1016/j.ccr.2005.02.018 Bruckert, 2016, Normalization of reverse transcription quantitative PCR data during ageing in distinct cerebral structures, Mol. Neurobiol., 53, 1540, 10.1007/s12035-015-9114-5